Published 2002 | Version v1.0.0
Journal Article Open

Nonstimulant Therapy for ADHD

Abstract

The results of a multicenter, open-label, dose-titration study of GW320659, a novel norepinephrine and dopamine reuptake inhibitor, are reported from GlaxoSmithKline, Research Triangle Park, NC.

Files

PNB-16-63.pdf

Files (1.5 MB)

Name Size Download all
md5:f48b5ad1cef3a7a23342aae327eecf7b
1.5 MB Preview Download

Additional details

Identifiers

Other
PNB-16-63

Dates

Created
2002
When the item was originally created.